Lubiprostone Capsule
Product Images NDC 70771-1764

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lubiprostone (NDC 70771-1764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8 Mcg Label (D529a527 D19e 4cec A117 Ddc6cab4a8b1 01)

Lubiprostone Capsules 8 mcg oral capsules label showing 60 capsules per container. The label includes directions to swallow whole and not break apart or chew. It states the package is child-resistant, storage instructions between 20°C to 25°C, and manufacturer information as Zydus Lifesciences Limited, Ahmedabad, India. The label features the Zydus logo and the NDC number 70771-1763-6.*

FDA Label Image

24 Mcg Label (D529a527 D19e 4cec A117 Ddc6cab4a8b1 02)

Label for Lubiprostone Capsules 24 mcg by Zydus Lifesciences Limited. The label states the product is for oral use and contains 60 capsules per package. Instructions include swallowing whole without breaking or chewing. Storage instructions, child-resistant packaging notice, and manufacturer details from Ahmedabad, India, are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.